|
C4ORF34 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.28849999453595E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.36459999989481E-07 |
| Normal-vs-Stage2 |
1.448950E-04 |
| Normal-vs-Stage3 |
5.201600E-04 |
| Normal-vs-Stage4 |
5.276300E-03 |
| Stage1-vs-Stage2 |
7.645200E-01 |
| Stage1-vs-Stage3 |
4.362200E-01 |
| Stage1-vs-Stage4 |
8.406000E-01 |
| Stage2-vs-Stage3 |
7.103400E-01 |
| Stage2-vs-Stage4 |
9.879600E-01 |
| Stage3-vs-Stage4 |
7.795800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.47579999518899E-08 |
| Normal-vs-AfricanAmerican |
1.8172000000316E-06 |
| Normal-vs-Asian |
1.262340E-03 |
| Caucasian-vs-AfricanAmerican |
8.894200E-01 |
| Caucasian-vs-Asian |
4.792200E-01 |
| AfricanAmerican-vs-Asian |
5.204800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.3037574332393E-12 |
| Normal-vs-Female |
2.496300E-03 |
| Male-vs-Female |
3.202700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.80139999999396E-05 |
| Normal-vs-Extreme_Weight |
9.40136857252583E-12 |
| Normal-vs-Obese |
1.099210E-03 |
| Normal-vs-Extreme_Obese |
5.380400E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.594200E-01 |
| Normal_Weight-vs-Obese |
2.604400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.616600E-01 |
| Extreme_Weight-vs-Obese |
1.090340E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.491600E-01 |
| Obese-vs-Extreme_Obese |
3.859400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.75678999999596E-05 |
| Normal-vs-Age(41-60Yrs) |
4.77590000003136E-06 |
| Normal-vs-Age(61-80Yrs) |
1.02070000007615E-07 |
| Normal-vs-Age(81-100Yrs) |
1.53370000033348E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.547200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.929400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.716200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.116000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.377900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.736000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.01529903876008E-11 |
| Normal-VS-Type2 PRCC |
7.58100000000095E-05 |
| Normal-VS-KIRP CIMP |
2.659500E-02 |
| Normal-VS-Unclassified PRCC |
8.204600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.919800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.132630E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.146400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.131200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.642200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.413000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.98250002472855E-09 |
| Normal-vs-N1 |
1.342240E-03 |
| Normal-vs-N2 |
1.314800E-01 |
| N0-vs-N1 |
8.494200E-02 |
| N0-vs-N2 |
2.929200E-01 |
| N1-vs-N2 |
8.770400E-01 |
|
|
